Inhibitory Antibodies
-
F1338 Anti-PDCD1/PD-1/CD279 Antibody (Zimberelimab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Zimberelimab) -
F1339 Anti-PDCD1/PD-1/CD279 Antibody (Camrelizumab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Camrelizumab) -
F1340 Anti-PDCD1/PD-1/CD279 Antibody (Nivolumab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Nivolumab) -
F1341 Anti-PDCD1/PD-1/CD279 Antibody (Pembrolizumab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Pembrolizumab) -
F1342 Anti-PDCD1/PD-1/CD279 Antibody (Serplulimab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Serplulimab) -
F1343 Anti-PDCD1/PD-1/CD279 Antibody (Spartalizumab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Spartalizumab) -
F1344 Anti-TLR2/CD282 Antibody (Tomaralimab)Summary: Anti-TLR2/CD282 Antibody (Tomaralimab) -
F1345 Anti-CD19 Antibody (Inebilizumab)Summary: Anti-CD19 Antibody (Inebilizumab) -
F1346 Anti-CD6 Antibody (Itolizumab)Summary: Anti-CD6 Antibody (Itolizumab) -
F1347 Anti-CD74 Antibody (Milatuzumab)Summary: Anti-CD74 Antibody (Milatuzumab)

